CSPC Dophen Corp. Information

CSPC Dophen Corporation is a biopharmaceutical research company aiming to develop protein and antibody therapeutics. Its patented novel antibody-drug conjugation platform underlies its success in the submission of its first ADC-based IND application. Since undergoing new leadership & corporate restructuring in August 2017, Dophen is expanding its capacity in therapeutic antibody discovery as well as ADC R&D. Its antibody discovery program is recruiting qualified scientists to develop novel therapeutic antibodies and ADCs. Dophen is located in the newly developed Natomas district of the city of Sacramento, with plenty of shopping, entertainment, and affordable housing possibilities around. Dophen is a fully owned subsidiary of CSPC Pharmaceutical Group Limited, a public pharmaceutical company listed in Hong Kong Stock Exchange (1093: Hong Kong).